NASDAQ:FOMX - Foamix Pharmaceuticals News Headlines

$2.97
+0.07 (+2.41 %)
(As of 08/22/2019 01:21 AM ET)
Today's Range
$2.87
Now: $2.97
$3.03
50-Day Range
$2.02
MA: $2.46
$3.16
52-Week Range
$1.97
Now: $2.97
$7.60
Volume646,554 shs
Average Volume434,737 shs
Market Capitalization$181.18 million
P/E RatioN/A
Dividend YieldN/A
Beta1.62

Headlines

Foamix Pharmaceuticals (NASDAQ FOMX) News Headlines

Source:
DateHeadline
This Latest Target Price On Foamix (FOMX) Stock Looks Positively FrothyThis Latest Target Price On Foamix (FOMX) Stock Looks Positively Frothy
finance.yahoo.com - August 14 at 10:00 AM
Edited Transcript of FOMX earnings conference call or presentation 8-Aug-19 12:30pm GMTEdited Transcript of FOMX earnings conference call or presentation 8-Aug-19 12:30pm GMT
finance.yahoo.com - August 13 at 8:07 AM
With 2 NDAs Already Submitted To The FDA, Foamix Sets Itself Up For A Monumental PeriodWith 2 NDAs Already Submitted To The FDA, Foamix Sets Itself Up For A Monumental Period
seekingalpha.com - August 13 at 12:54 AM
Foamix Pharmaceuticals (NASDAQ:FOMX) Rating Reiterated by Bank of AmericaFoamix Pharmaceuticals (NASDAQ:FOMX) Rating Reiterated by Bank of America
www.americanbankingnews.com - August 10 at 10:33 PM
Bank of America Sees Over 350% Upside in Foamix (FOMX) StockBank of America Sees Over 350% Upside in Foamix (FOMX) Stock
finance.yahoo.com - August 10 at 11:20 AM
Foamix Reports Second Quarter 2019 Financial Results and Provides Corporate UpdateFoamix Reports Second Quarter 2019 Financial Results and Provides Corporate Update
www.nasdaq.com - August 7 at 9:53 PM
Foamix Pharmaceuticals Ltd (NASDAQ:FOMX) Given Average Recommendation of "Buy" by BrokeragesFoamix Pharmaceuticals Ltd (NASDAQ:FOMX) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - August 7 at 4:37 PM
Foamix Submits New Drug Application to U.S. FDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular RosaceaFoamix Submits New Drug Application to U.S. FDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular Rosacea
finance.yahoo.com - August 5 at 10:08 AM
Foamix Pharmaceuticals (FOMX) to Release Earnings on WednesdayFoamix Pharmaceuticals (FOMX) to Release Earnings on Wednesday
www.americanbankingnews.com - July 31 at 9:21 AM
Foamix up 11% premarket on $64M capital raiseFoamix up 11% premarket on $64M capital raise
seekingalpha.com - July 30 at 9:46 AM
Foamix Announces $64 Million Capital Financing Investment by Perceptive Advisors and OrbiMedFoamix Announces $64 Million Capital Financing Investment by Perceptive Advisors and OrbiMed
finance.yahoo.com - July 30 at 9:46 AM
Foamix Pharmaceuticals to Report Second Quarter 2019 Financial Results on August 8Foamix Pharmaceuticals to Report Second Quarter 2019 Financial Results on August 8
finance.yahoo.com - July 24 at 12:45 PM
Do Directors Own Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) Shares?Do Directors Own Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) Shares?
finance.yahoo.com - July 11 at 8:43 AM
Foamix: Unjustified Sell-Off Continues Despite Upcoming CatalystsFoamix: Unjustified Sell-Off Continues Despite Upcoming Catalysts
seekingalpha.com - July 3 at 8:52 AM
Foamix Announces Publication of Phase 3 FMX101 Acne Study in Journal of American Academy of DermatologyFoamix Announces Publication of Phase 3 FMX101 Acne Study in Journal of American Academy of Dermatology
finance.yahoo.com - June 4 at 8:52 AM
Foamix Pharmaceuticals (FOMX) Q1 2019 Earnings Call TranscriptFoamix Pharmaceuticals (FOMX) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 9 at 7:20 PM
Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX): The Best Of Both WorldsFoamix Pharmaceuticals Ltd. (NASDAQ:FOMX): The Best Of Both Worlds
finance.yahoo.com - May 9 at 7:20 PM
Edited Transcript of FOMX earnings conference call or presentation 8-May-19 12:30pm GMTEdited Transcript of FOMX earnings conference call or presentation 8-May-19 12:30pm GMT
finance.yahoo.com - May 9 at 8:48 AM
Foamix Pharmaceuticals Ltd. (FOMX) CEO David Domzalski on Q1 2019 Results - Earnings Call TranscriptFoamix Pharmaceuticals Ltd. (FOMX) CEO David Domzalski on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 8 at 7:17 PM
Foamix (FOMX) Reports Q1 Loss, Misses Revenue EstimatesFoamix (FOMX) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 8 at 8:49 AM
Foamix Reports First Quarter 2019 Financial Results and Provides Corporate UpdateFoamix Reports First Quarter 2019 Financial Results and Provides Corporate Update
www.globenewswire.com - May 7 at 6:39 PM
Foamix Pharmaceuticals beats by $0.01, misses on revenueFoamix Pharmaceuticals beats by $0.01, misses on revenue
seekingalpha.com - May 7 at 6:39 PM
Foamix to Present Late Breaking Data at the 77th Annual Meeting of the Society for Investigative DermatologyFoamix to Present Late Breaking Data at the 77th Annual Meeting of the Society for Investigative Dermatology
finance.yahoo.com - April 29 at 8:39 AM
Foamix Pharmaceuticals First Quarter 2019 Financial Results Conference Call & Webcast Scheduled for May 8Foamix Pharmaceuticals First Quarter 2019 Financial Results Conference Call & Webcast Scheduled for May 8
finance.yahoo.com - April 24 at 8:47 AM
Foamix: Looking For An Entry Before The CatalystsFoamix: Looking For An Entry Before The Catalysts
seekingalpha.com - April 16 at 7:20 PM
This Small-Cap Biotech Stock Could Triple in 2019This Small-Cap Biotech Stock Could Triple in 2019
finance.yahoo.com - April 11 at 7:20 PM
What Kind Of Share Price Volatility Should You Expect For Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)?What Kind Of Share Price Volatility Should You Expect For Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)?
finance.yahoo.com - April 4 at 7:24 PM
Foamix Announces Settlement of Litigation with Perrigo Relating to Finacea FoamFoamix Announces Settlement of Litigation with Perrigo Relating to Finacea Foam
finance.yahoo.com - April 2 at 9:35 AM
FDA accepts Foamix NDA for acne treatment FMX101; shares up 4% premarketFDA accepts Foamix NDA for acne treatment FMX101; shares up 4% premarket
seekingalpha.com - March 7 at 9:01 AM
Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe AcneFoamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne
finance.yahoo.com - March 7 at 9:01 AM
Foamix Pharmaceuticals to Present at the Cowen & Company 39th Annual Health Care Conference - NasdaqFoamix Pharmaceuticals to Present at the Cowen & Company 39th Annual Health Care Conference - Nasdaq
www.nasdaq.com - March 6 at 7:04 PM
Foamix Pharmaceuticals to Present at the Cowen & Company 39th Annual Health Care ConferenceFoamix Pharmaceuticals to Present at the Cowen & Company 39th Annual Health Care Conference
finance.yahoo.com - March 6 at 8:59 AM
Edited Transcript of FOMX earnings conference call or presentation 1-Mar-19 1:30pm GMTEdited Transcript of FOMX earnings conference call or presentation 1-Mar-19 1:30pm GMT
finance.yahoo.com - March 2 at 8:32 AM
Foamix -- with Late-Stage Candidates in Acne and Rosacea -- to Participate at American Academy of Dermatology Annual Meeting - GlobeNewswireFoamix -- with Late-Stage Candidates in Acne and Rosacea -- to Participate at American Academy of Dermatology Annual Meeting - GlobeNewswire
globenewswire.com - February 28 at 6:41 PM
Foamix Announces Positive Results from Phase 3 Open-Label Safety Study Evaluating FMX103 Topical Minocycline Foam for Treatment up to 1 Year - GlobeNewswireFoamix Announces Positive Results from Phase 3 Open-Label Safety Study Evaluating FMX103 Topical Minocycline Foam for Treatment up to 1 Year - GlobeNewswire
globenewswire.com - February 28 at 6:41 PM
Foamix Reports Fiscal Year 2018 Financial Results and Provides Corporate Update - GlobeNewswireFoamix Reports Fiscal Year 2018 Financial Results and Provides Corporate Update - GlobeNewswire
globenewswire.com - February 28 at 6:41 PM
Foamix Reports Fiscal Year 2018 Financial Results and Provides Corporate UpdateFoamix Reports Fiscal Year 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - February 28 at 6:41 PM
Foamix up 4% premarket positive FMX103 dataFoamix up 4% premarket positive FMX103 data
seekingalpha.com - February 27 at 6:56 PM
How Many Insiders Bought Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) Shares?How Many Insiders Bought Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) Shares?
finance.yahoo.com - February 27 at 6:56 PM
Foamix -- with Late-Stage Candidates in Acne and Rosacea -- to Participate at American Academy of Dermatology Annual MeetingFoamix -- with Late-Stage Candidates in Acne and Rosacea -- to Participate at American Academy of Dermatology Annual Meeting
finance.yahoo.com - February 26 at 8:58 AM
Will Foamix (FOMX) Report Negative Earnings Next Week? What You Should KnowWill Foamix (FOMX) Report Negative Earnings Next Week? What You Should Know
finance.yahoo.com - February 21 at 6:34 PM
Foamix Pharmaceuticals Fourth Quarter Financial Results Conference Call & Webcast Scheduled for March 1Foamix Pharmaceuticals Fourth Quarter Financial Results Conference Call & Webcast Scheduled for March 1
finance.yahoo.com - February 14 at 8:51 AM
Foamix Announces Appointment of Sharon Barbari to Board of DirectorsFoamix Announces Appointment of Sharon Barbari to Board of Directors
finance.yahoo.com - January 23 at 8:38 AM
Are Foamix Pharmaceuticals Ltd.’s (NASDAQ:FOMX) Interest Costs Too High?Are Foamix Pharmaceuticals Ltd.’s (NASDAQ:FOMX) Interest Costs Too High?
finance.yahoo.com - January 22 at 6:03 PM
Foamix Submits New Drug Application to U.S. FDA Seeking Approval of FMX101 in Treatment of Moderate-to-Severe AcneFoamix Submits New Drug Application to U.S. FDA Seeking Approval of FMX101 in Treatment of Moderate-to-Severe Acne
finance.yahoo.com - December 21 at 8:45 AM
Is Foamix Pharmaceuticals Ltd (FOMX) A Good Stock To Buy?Is Foamix Pharmaceuticals Ltd (FOMX) A Good Stock To Buy?
finance.yahoo.com - December 17 at 8:44 AM
Could Foamix Pharmaceuticals Ltd.’s (NASDAQ:FOMX) Investor Composition Influence The Stock Price?Could Foamix Pharmaceuticals Ltd.’s (NASDAQ:FOMX) Investor Composition Influence The Stock Price?
finance.yahoo.com - December 14 at 5:23 PM
Foamix Pharmaceuticals appoints Matt Wiley as Chief Commercial OfficerFoamix Pharmaceuticals appoints Matt Wiley as Chief Commercial Officer
seekingalpha.com - November 27 at 9:06 AM
Foamix Announces Appointment of Anthony Bruno to Board of DirectorsFoamix Announces Appointment of Anthony Bruno to Board of Directors
finance.yahoo.com - November 19 at 8:38 AM
Foamix Pharmaceuticals (FOMX) CEO Dave Domzalski on Q3 2018 Results - Earnings Call TranscriptFoamix Pharmaceuticals' (FOMX) CEO Dave Domzalski on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 8:42 AM
This page was last updated on 8/22/2019 by MarketBeat.com Staff

Featured Article: What is the Beige Book?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel